Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Endometrial Cancer
Research from University of Munich has provided new information about endometrial cancer
July 8th, 2009
According to recent research from Munich, Germany, "Inhibins are dimeric glycoproteins, composed of an alpha-subunit (inhibin-alpha) and one of two possible beta-subunits (beta A or beta B), with substantial roles in human reproduction and in endocrine-responsive tumours. The aims of this study were to determine the distribution of inhibin-alpha, -beta A and -beta B subunits in malignant human endometrial tissue and the assessment of an association with specific clinicopathologic tumour features and clinical outcome." "A series of 302 endometrial cancer tissue samples were immunohistochemically analysed with monoclonal antibodies against inhibin subunits. The...
Source: Immunotherapy Weekly (2009-07-08)
|
